Table 1. Epidemiological and clinical characteristics at diagnosis of the 713-patient cohort treated with multibacillary multidrug therapy at Souza Araújo Outpatient Clinic, Fiocruz, during 1997–2017.
Characteristic | Number of patients (valid %) | |
---|---|---|
Sex | ||
Male | 509 (71.4) | |
Female | 204 (28.6) | |
Educational level (years) | ||
|
80 (11.4) | |
<9 | 357 (50.8) | |
9–11 | 134 (19.1) | |
>11 | 131 (18.7) | |
Not available | 11 | |
Clinical Form | ||
Lepromatous leprosy | 330 (46.3) | |
Borderline-Lepromatous | 237 (33.2) | |
Borderline -Borderline | 141 (19.7) | |
Borderline-Tuberculoid | 3 (0.4) | |
Indeterminate | 2 (0.3) | |
Number of skin lesions | ||
Single lesion | 21 (3.6) | |
2–5 lesions | 46 (7.8) | |
6–10 lesions | 50 (8.5) | |
11–20 lesions | 294 (50.2) | |
More than 20 lesions | 175 (29.9) | |
Not available | 127 | |
Treatment duration (months)* | ||
12 | 202 (28.3) | |
13–18 | 491 (68.9) | |
> 18 | 20 (2.8) | |
Disability grade | Initial | RFT |
0 (no disability) | 362 (56.5) | 331 (55.9) |
1 (anaesthesia/paresis) | 180 (28.1) | 187 (31.6) |
2 (deformity/ulcer) | 99 (15.4) | 74 (12.5) |
Not available | 72 | 121 |
Bacillary index | Initial | RFT (n = 531) |
0 | 0 (0.0) | 98 (18.4) |
0.05–3.38 | 343 (48.5) | 251 (47.2) |
≥3.5 | 367 (51.5) | 183 (34.4) |
Median | 3.50 | 2.50 |
Minimum, maximum | 0.16, 6.00 | 0.0, 5.90 |
First and third quartiles | 1.75, 4.25 | 0.50, 3.76 |
*All patients received a twelve-dose MB-MDT scheme, but some were non-compliant with the monthly schedule or had to delay treatment due to adverse effect. Treatment duration was calculated using the date the patient received his/her first supervised dose until he/she received the last supervised dose, regardless the time taken to restart the treatment in case of non-compliance.
RFT = release from treatment